Ossium (Series B)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$175,000,000
Company Info
Founders
Kevin Caldwell
Market
Healthcare & Wellness
Coinvestors
Vivo Capital,Manta Ray,First Round Capital,General Catalyst
Company Description

Develops and manufactures cell therapy products that cure leukemia and other blood cancers, improve organ transplantation, treat radiation poisoning, and heal tissue damage. Ossium Health builds a bone marrow bank to treat blood cancers.